1st Quarter - Report · 2026

Filing UUID: e376f5ca-5480-4127-bc3a-9e35051ba1d1
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-18 19:43:49
Income (reported): $100,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

THORN RUN PARTNERS

Government Affairs Firm

Contact: W. CHRISTOPHER LAMOND
Phone: +1 202-688-0225
Address: zip:20003, city:Washington, state:DC, street:100 M Street, SE Suite 750

Client

THE BIOSIMILARS FORUM

Non-profit Organization

State: DC
Country: US
Government-entity client: false
Effective date: 2019-01-01

Issues lobbied + lobbyists

`MMM` — Medicare/Medicaid

Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.

Lobbyists: STUART CHAPMAN (covered position: Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee); ALEX DELPIZZO (covered position: Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee); mrs THAYER SURETTE ROBERTS

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

`HCR` — Health Issues

Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.

Lobbyists: STUART CHAPMAN; ALEX DELPIZZO; mrs THAYER SURETTE ROBERTS